TREVENA INC (TRVN)
Trevena, Inc. is a biopharmaceutical company, which focuses on developing and commercializing novel medicines for patients affected by central nervous system, or CNS, disorders. Its product candidates include Oliceridine injection, TRV250, TRV734, and TRV045. The company was founded by Maxine Gowen, Robert Joseph Lefkowitz, Scott DeWire, Howard A. Rockman, Jonathan Violin, and Erin Whalen on November 9, 2007 and is headquartered in Chesterbrook, PA.
Address
955 CHESTERBROOK BOULEVARD
CHESTERBROOK, PA 19087
Founded
2007
Number of Employees
23
Website
http://www.trevena.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)